COGT — Cogent Biosciences Share News
0.000.00%
Last trade - 00:00Brief: Cogent Biosciences Announces Positive Top-Line Results Of APEX Trial Of Bezuclastinib In Patients With Advanced Systemic Mastocytosis
U.S. RESEARCH ROUNDUP-Alignment Healthcare, BJ's Wholesale Club Holdings, Hyatt Hotels
Nasdaq biotech index hits record high, set to gain nearly 5% this week
Brief: Cogent Biosciences Enters Underwriting Agreement With Jefferies, J.P.Morgan LLC
U.S. STOCKS ON THE MOVE-TransDigm, Citigroup, Cisco Systems
U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
Cogent Biosciences steady after upsized $500 mln capital raise
Brief: Cogent Biosciences Announces Pricing Of Concurrent Public Offerings Of Common Stock And 1.625% Convertible Senior Notes Due 2031
U.S. STOCKS ON THE MOVE-Surmodics, Cheniere Energy, American Public Education
U.S. STOCKS ON THE MOVE-Surmodics, Energy stocks, American Public Education
Cogent Biosciences slips as co eyes capital raise after stock surge
Cogent Biosciences launches $400 mln equity, convertible deals after stock more than doubles
U.S. STOCKS ON THE MOVE-Eli Lilly, Fossil, Papa John's
Cogent hits 7-year high as combo drug slows cancer progression in trial
U.S. STOCKS ON THE MOV-Guardant Health, Tower Semiconductor, GlobalFoundries
U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks
Cogent Biosciences soars as combo drug slows cancer progression in trial
Cogent Biosciences posts wider Q3 loss as costs rise